A search for genes which, at elevated copy number, could suppress the growth defect in a strain disrupted at the KRE9 locus has identified the SKN7 gene. SKN7 was mapped to the right arm of chromosome VIII and is predicted to encode a 70-kDa protein, Skn7p, with a region of homology to the DNA binding domain of the Saccharomyces cerevisiae heat shock transcription factor, Hsflp. Skn7p also has a domain which shows similarity to the prokaryotic receiver modules found on an extensive family of two-component response regulators, including the products of the rcsC and barA genes. SKN7 did not suppress other mutations in the (1-*6)-1-glucan biosynthetic pathway, suggesting that SKN7 does not act as a general bypass suppressor of this glucan.
This is the first veterinary study demonstrating an association between prognosis of patients with TSCC and stage at the time of presentation, with long survival times demonstrated for dogs with early-stage disease following an initial treatment protocol that included surgery and chemotherapy. There was no clear association between long survival and additional surgeries for progressive disease; however; further investigation is warranted.
A xenogeneic DNA vaccination has been licensed for use in dogs with locally controlled
stage II and III oral malignant melanoma (OMM). At present, there are limited outcome data
for dogs with OMM treated with surgery and immunotherapy. The aim of this study is to
retrospectively review the outcome and survival of 32 dogs affected by OMM that were
treated with a combination of surgery and the xenogeneic DNA vaccination (with the
addition of radiotherapy in some cases) and to determine the influence of surgical margins
and delay in receiving vaccination. The overall median survival time (MST) was 335 days
(95% CI: 301–540 days), and the overall median progression-free survival (PFS) was 160
days (mean 182 days, 95% CI: 132–232 days). Stage, completeness of surgical margins and
delay in administration of the vaccine did not appear to statistically influence survival
or PFS, although these results may reflect the low statistical power of the study due to
small numbers. Further studies are required to assess whether the addition of any adjuvant
treatment to surgery, including immunotherapy, is able to significantly prolong survival
in cases of canine oral melanoma.
Little information is available on the occurrence of neoplasms in dogs up to the age of 12 months. This is a retrospective review of histopathological diagnoses of neoplasia in dogs up to the age of 12 months based on biopsy specimens submitted to a commercial veterinary diagnostic laboratory in the United Kingdom between 1993 and 2008. In 20 280 histological submissions, 9522 neoplasms were identified. Canine cutaneous histiocytoma (n = 8465; 89%) was the most common histological type. Neoplasms other than histiocytoma (n = 1057; 11%) were grouped as benign epithelial (n = 375; 4%), haematopoietic (n = 229; 2%), benign mesenchymal (n = 145; 2%), miscellaneous (n = 118; 1%), non-hematopoietic malignant mesenchymal (n = 118; 1%) or malignant epithelial tumours (n = 72; <1%). Excluding canine cutaneous histiocytoma, 52% of tumours (n = 547) were benign, and 66% were from the skin or soft tissues. These data provide valuable epidemiological information on neoplasms occurring in juvenile dogs in the United Kingdom.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.